FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:AFF1-WWOX

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: AFF1-WWOX
FusionPDB ID: 2672
FusionGDB2.0 ID: 2672
HgeneTgene
Gene symbol

AFF1

WWOX

Gene ID

4299

51741

Gene nameAF4/FMR2 family member 1WW domain containing oxidoreductase
SynonymsAF4|MLLT2|PBM1D16S432E|EIEE28|FOR|FRA16D|HHCMA56|PRO0128|SCAR12|SDR41C1|WOX1
Cytomap

4q21.3-q22.1

16q23.1-q23.2

Type of geneprotein-codingprotein-coding
DescriptionAF4/FMR2 family member 1ALL1-fused gene from chromosome 4 proteinmyeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 2pre-B-cell monocytic leukemia partner 1proto-oncogene AF4WW domain-containing oxidoreductaseWW domain-containing protein WWOXfragile site FRA16D oxidoreductaseshort chain dehydrogenase/reductase family 41C member 1
Modification date2020031320200313
UniProtAcc

P51825

Main function of 5'-partner protein:
.
Ensembl transtripts involved in fusion geneENST idsENST00000307808, ENST00000395146, 
ENST00000544085, ENST00000511996, 
ENST00000355860, ENST00000408984, 
ENST00000565791, ENST00000569818, 
ENST00000402655, ENST00000406884, 
ENST00000566780, ENST00000539474, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score27 X 51 X 13=1790130 X 23 X 10=6900
# samples 6836
** MAII scorelog2(68/17901*10)=-4.71836162613835
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(36/6900*10)=-4.26052755022322
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: AFF1 [Title/Abstract] AND WWOX [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: AFF1 [Title/Abstract] AND WWOX [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)AFF1(88036451)-WWOX(79245505), # samples:2
Anticipated loss of major functional domain due to fusion event.AFF1-WWOX seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AFF1-WWOX seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AFF1-WWOX seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
AFF1-WWOX seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
AFF1-WWOX seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
AFF1-WWOX seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
AFF1-WWOX seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
AFF1-WWOX seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneWWOX

GO:0030178

negative regulation of Wnt signaling pathway

19465938

TgeneWWOX

GO:0071560

cellular response to transforming growth factor beta stimulus

19366691



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:88036451/chr16:79245505)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across AFF1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across WWOX (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000395146AFF1chr488036451+ENST00000539474WWOXchr1679245505+380127412662929887
ENST00000307808AFF1chr488036451+ENST00000539474WWOXchr1679245505+392528654203053877
ENST00000544085AFF1chr488036451+ENST00000539474WWOXchr1679245505+262315631321751539

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000395146ENST00000539474AFF1chr488036451+WWOXchr1679245505+0.0034716290.9965283
ENST00000307808ENST00000539474AFF1chr488036451+WWOXchr1679245505+0.0039283090.9960717
ENST00000544085ENST00000539474AFF1chr488036451+WWOXchr1679245505+0.0143901450.9856098

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for AFF1-WWOX

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
AFF1chr488036451WWOXchr16792455051563477SSDSSSKLAKKRKQQGAATTVYCAAV
AFF1chr488036451WWOXchr16792455052741825SSDSSSKLAKKRKQQGAATTVYCAAV
AFF1chr488036451WWOXchr16792455052865815SSDSSSKLAKKRKQQGAATTVYCAAV

Top

Potential FusionNeoAntigen Information of AFF1-WWOX in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AFF1-WWOX_88036451_79245505.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AFF1-WWOXchr488036451chr16792455052865HLA-B48:01KQQGAATTV0.98960.88031221
AFF1-WWOXchr488036451chr16792455052865HLA-B13:02KQQGAATTV0.80380.94131221
AFF1-WWOXchr488036451chr16792455052865HLA-A02:21KQQGAATTV0.7810.8461221
AFF1-WWOXchr488036451chr16792455052865HLA-B39:13KQQGAATTV0.56570.9811221
AFF1-WWOXchr488036451chr16792455052865HLA-B13:01KQQGAATTV0.56080.99271221
AFF1-WWOXchr488036451chr16792455052865HLA-B52:01KQQGAATTV0.01110.98461221
AFF1-WWOXchr488036451chr16792455052865HLA-B15:01KQQGAATTVY0.99990.81951222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:25KQQGAATTVY0.97310.91451222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:03KQQGAATTVY0.80110.78771222
AFF1-WWOXchr488036451chr16792455052865HLA-B13:02RKQQGAATTV0.35330.92161121
AFF1-WWOXchr488036451chr16792455052865HLA-B15:01RKQQGAATTVY0.98130.84521122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:25RKQQGAATTVY0.96920.9081122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:03RKQQGAATTVY0.85860.78411122
AFF1-WWOXchr488036451chr16792455052865HLA-B13:02KRKQQGAATTV0.50810.9121021
AFF1-WWOXchr488036451chr16792455052865HLA-A02:05KQQGAATTV0.92930.69261221
AFF1-WWOXchr488036451chr16792455052865HLA-B48:03KQQGAATTV0.83330.85041221
AFF1-WWOXchr488036451chr16792455052865HLA-B15:04KQQGAATTV0.79490.96311221
AFF1-WWOXchr488036451chr16792455052865HLA-B39:08KQQGAATTV0.58950.92151221
AFF1-WWOXchr488036451chr16792455052865HLA-B15:07KQQGAATTVY0.99790.571222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:04KQQGAATTVY0.99560.86321222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:05KQQGAATTVY0.81440.88051222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:05RKQQGAATTVY0.91860.8921122
AFF1-WWOXchr488036451chr16792455052865HLA-B40:40KQQGAATTV0.98320.68871221
AFF1-WWOXchr488036451chr16792455052865HLA-B15:73KQQGAATTV0.86250.97881221
AFF1-WWOXchr488036451chr16792455052865HLA-B40:12KQQGAATTV0.83330.85041221
AFF1-WWOXchr488036451chr16792455052865HLA-A02:14KQQGAATTV0.78710.82841221
AFF1-WWOXchr488036451chr16792455052865HLA-A02:06KQQGAATTV0.7810.8461221
AFF1-WWOXchr488036451chr16792455052865HLA-B15:30KQQGAATTV0.7220.96181221
AFF1-WWOXchr488036451chr16792455052865HLA-B39:02KQQGAATTV0.63540.98121221
AFF1-WWOXchr488036451chr16792455052865HLA-B40:49KQQGAATTV0.56410.83721221
AFF1-WWOXchr488036451chr16792455052865HLA-B40:21KQQGAATTV0.5240.89541221
AFF1-WWOXchr488036451chr16792455052865HLA-B15:33KQQGAATTVY0.99990.81951222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:125KQQGAATTVY0.99990.81951222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:50KQQGAATTVY0.99990.75661222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:27KQQGAATTVY0.99990.80071222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:34KQQGAATTVY0.99990.81951222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:135KQQGAATTVY0.99990.83711222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:24KQQGAATTVY0.99970.85181222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:12KQQGAATTVY0.99850.77971222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:53KQQGAATTVY0.99760.7821222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:35KQQGAATTVY0.99580.69511222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:54KQQGAATTVY0.99270.77281222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:39KQQGAATTVY0.97460.82621222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:68KQQGAATTVY0.93440.51051222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:20KQQGAATTVY0.82510.93921222
AFF1-WWOXchr488036451chr16792455052865HLA-B35:28KQQGAATTVY0.80350.95381222
AFF1-WWOXchr488036451chr16792455052865HLA-B48:02KQQGAATTVY0.57180.94511222
AFF1-WWOXchr488036451chr16792455052865HLA-B15:135RKQQGAATTVY0.98140.85951122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:34RKQQGAATTVY0.98130.84521122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:125RKQQGAATTVY0.98130.84521122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:33RKQQGAATTVY0.98130.84521122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:39RKQQGAATTVY0.97280.82351122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:35RKQQGAATTVY0.97020.74951122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:50RKQQGAATTVY0.96210.85041122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:53RKQQGAATTVY0.94440.81891122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:54RKQQGAATTVY0.90320.80791122
AFF1-WWOXchr488036451chr16792455052865HLA-B48:02RKQQGAATTVY0.84570.93691122
AFF1-WWOXchr488036451chr16792455052865HLA-B15:68RKQQGAATTVY0.81670.54181122

Top

Potential FusionNeoAntigen Information of AFF1-WWOX in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AFF1-WWOX_88036451_79245505.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AFF1-WWOXchr488036451chr16792455052865DRB1-1102SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1102SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1103SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1103SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1103DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1103SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1111SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1111SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1116SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1116SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1121SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1136SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1136SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1141SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1141SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1141DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1141SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1148SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1148SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1155SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1155SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1155DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1155SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1159SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1159SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1159DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1163SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1163SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1163DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1163SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1165SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1165SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1170SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1170SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1176SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1176SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1176DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1176SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1185SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1185SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1185DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1185SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1301SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1301SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1308SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1308SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1315SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1315SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1319SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1319SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1320SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1320SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1322SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1322SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1324SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1324SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1324DSSSKLAKKRKQQGA217
AFF1-WWOXchr488036451chr16792455052865DRB1-1324SKLAKKRKQQGAATT520
AFF1-WWOXchr488036451chr16792455052865DRB1-1335SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1335SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1351SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1351SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1352SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1352SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1353SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1353SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1357SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1357SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1359SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1359SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1363SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1363SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1364SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1364SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1368SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1368SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1369SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1369SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1370SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1370SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1372SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1372SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1375SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1375SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1378SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1378SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1379SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1379SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1380SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1380SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1383SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1383SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1384SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1384SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1387SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1387SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1391SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1391SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1392SSKLAKKRKQQGAAT419
AFF1-WWOXchr488036451chr16792455052865DRB1-1392SSSKLAKKRKQQGAA318
AFF1-WWOXchr488036451chr16792455052865DRB1-1398SSKLAKKRKQQGAAT419

Top

Fusion breakpoint peptide structures of AFF1-WWOX

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4368KLAKKRKQQGAATTAFF1WWOXchr488036451chr16792455052865

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of AFF1-WWOX

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4368KLAKKRKQQGAATT-6.07233-6.07953
HLA-B52:013W394368KLAKKRKQQGAATT-5.45645-5.46365
HLA-A24:025HGA4368KLAKKRKQQGAATT-3.85827-3.86547
HLA-B44:053DX84368KLAKKRKQQGAATT-4.76301-4.77021

Top

Vaccine Design for the FusionNeoAntigens of AFF1-WWOX

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
AFF1-WWOXchr488036451chr16792455051021KRKQQGAATTVAAGAGAAAGCAACAGGGAGCTGCCACCACCGTG
AFF1-WWOXchr488036451chr16792455051121RKQQGAATTVAGAAAGCAACAGGGAGCTGCCACCACCGTG
AFF1-WWOXchr488036451chr16792455051122RKQQGAATTVYAGAAAGCAACAGGGAGCTGCCACCACCGTGTAC
AFF1-WWOXchr488036451chr16792455051221KQQGAATTVAAGCAACAGGGAGCTGCCACCACCGTG
AFF1-WWOXchr488036451chr16792455051222KQQGAATTVYAAGCAACAGGGAGCTGCCACCACCGTGTAC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
AFF1-WWOXchr488036451chr1679245505217DSSSKLAKKRKQQGAGACAGCTCAAGCAAGTTGGCCAAAAAGAGAAAGCAACAGGGAGCT
AFF1-WWOXchr488036451chr1679245505318SSSKLAKKRKQQGAAAGCTCAAGCAAGTTGGCCAAAAAGAGAAAGCAACAGGGAGCTGCC
AFF1-WWOXchr488036451chr1679245505419SSKLAKKRKQQGAATTCAAGCAAGTTGGCCAAAAAGAGAAAGCAACAGGGAGCTGCCACC
AFF1-WWOXchr488036451chr1679245505520SKLAKKRKQQGAATTAGCAAGTTGGCCAAAAAGAGAAAGCAACAGGGAGCTGCCACCACC

Top

Information of the samples that have these potential fusion neoantigens of AFF1-WWOX

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCAFF1-WWOXchr488036451ENST00000307808chr1679245505ENST00000539474TCGA-DX-AB35-01A

Top

Potential target of CAR-T therapy development for AFF1-WWOX

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to AFF1-WWOX

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to AFF1-WWOX

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource